Standard of Care: Medications & Topical Treatments
At a Glance
Postherpetic neuralgia is usually managed with nerve-pain medicines such as gabapentin, pregabalin, certain antidepressants, or topical lidocaine and capsaicin. Treatment is individualized, and medicines should be adjusted or stopped only with clinician guidance.
Managing post-infectious neuralgia—particularly Postherpetic Neuralgia (PHN)—is less about “curing” the pain and more about calming a sensitized nervous system. Because nerve pain involves complex electrical and chemical changes, standard painkillers like ibuprofen or acetaminophen are rarely effective [1][2]. Instead, doctors use medications that specifically target how nerves send signals.
The First-Line Oral Medications
International guidelines generally support specific classes of oral medications for treating peripheral neuropathic pain, including established PHN [1][3].
1. Gabapentinoids (Gabapentin and Pregabalin)
These medications do not treat the virus; they work by binding to calcium channels on overactive nerves to “quiet” the pain signals [4][5].
- Individualized Titration: These drugs must be started low and increased slowly. Dose must be adjusted for kidney function and often age or frailty [4][6]. Never change or stop the dose without your prescriber.
- Common Side Effects: Both medications can cause somnolence (sleepiness), dizziness, peripheral edema (swelling in the ankles or legs), and gait instability (feeling unsteady on your feet) [4][5]. They carry risks of misuse/withdrawal and risk of severe respiratory depression when combined with opioids, alcohol, or other sedatives.
2. Antidepressants (TCAs and SNRIs)
Medications developed for depression are often used at lower doses for nerve pain. They help by increasing the body’s natural “pain-braking” chemicals (norepinephrine and serotonin) in the spinal cord [7][8].
- Tricyclic Antidepressants (TCAs): Medications like amitriptyline or nortriptyline can be effective but cause “anticholinergic” side effects like dry mouth, blurred vision, and constipation. They raise risks of orthostatic hypotension, falls, urinary retention, glaucoma exacerbation, and heart rhythm changes. They must be used with extreme caution in older adults [9][8].
- SNRIs: Medications like duloxetine or venlafaxine are also guideline-supported options for several peripheral neuropathic pain conditions.
Topical Treatments: Targeting Pain at the Source
If your pain is localized to a specific area, topical treatments can be highly effective because they deliver medicine directly to the damaged nerves with very little entering your bloodstream [10][11].
- Lidocaine 5% Patch: This is a medicated plaster you apply to the painful area. It works by numbing the surface nerves. It is often a preferred choice for older adults because it has low systemic risk, but it should only be used on intact, healed skin and within product-specific limits [10][12].
- Capsaicin 8% Patch: This high-concentration patch must be administered by trained medical staff. It uses the “heat” from chili peppers to desensitize the pain-sensing nerves [13][14]. Application commonly causes substantial temporary burning, erythema, and blood-pressure elevation, but may provide extended relief [14]. State evidence supports it strongly for PHN.
Common Pitfalls in Treatment
Success in treating neuralgia often depends as much on how the medicine is given as which medicine is chosen.
- Individualized Trials: Response, titration speed, and tolerability vary. Significant dizziness, confusion, swelling, mood changes, or breathing problems warrant earlier review by your doctor rather than waiting out a set timeframe [4][6].
- Premature Discontinuation vs. Tapering: It takes time to know if a drug works. However, if a medication must be stopped, it requires supervised tapering. Abrupt discontinuation of gabapentinoids or TCAs can cause severe withdrawal or rebound symptoms [4][7].
- Inappropriate Use of Opioids: While opioids are sometimes used for severe short-term pain, they are generally not recommended as routine first-line treatment for chronic neuralgia due to dependence and side effects [15][16].
Multimodal Therapy
If one medication isn’t enough, doctors may consider combination therapy, such as adding a topical patch to an oral medication. However, combined agents can increase sedation, falls, anticholinergic effects, and respiratory risk. Combinations require a clinician-led risk-benefit review [17][11]. In addition to medications, care should include gentle desensitization, physical therapy, sleep support, and psychological pain treatment.
Common questions in this guide
What medications are commonly used first for postherpetic neuralgia?
Can I use a lidocaine patch for localized postherpetic neuralgia?
What side effects can nerve pain medicines cause?
How does the capsaicin patch help postherpetic neuralgia?
Can I stop gabapentin or another neuralgia medicine suddenly?
Is it safe to combine a patch with an oral nerve-pain medicine?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my age, kidney function, and health history, which first-line medication is the safest starting point for me?
- 2.What is the specific individualized plan for titrating my medication?
- 3.What specific side effects should prompt me to call you rather than waiting out a trial period?
- 4.Since my pain is very localized, can we try a Lidocaine 5% patch before moving to oral medications?
- 5.If my pain is not controlled, what is the safe process for tapering off this drug and trying another?
- 6.Are there non-drug therapies, like physical therapy or psychological support, that we should add to my plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives.
Tang J, Zhang Y, Liu C, et al.
Current pain and headache reports 2023; (27(9)):307-319 doi:10.1007/s11916-023-01146-x.
PMID: 37493871 - 2
Post-herpetic Neuralgia: a Review.
Hadley GR, Gayle JA, Ripoll J, et al.
Current pain and headache reports 2016; (20(3)):17 doi:10.1007/s11916-016-0548-x.
PMID: 26879875 - 3
Utility of lidocaine as a topical analgesic and improvements in patch delivery systems.
Gudin J, Nalamachu S
Postgraduate medicine 2020; (132(1)):28-36 doi:10.1080/00325481.2019.1702296.
PMID: 31900074 - 4
Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ, Derry S, Bell RF, et al.
The Cochrane database of systematic reviews 2017; (6()):CD007938 doi:10.1002/14651858.CD007938.pub4.
PMID: 28597471 - 5
Pregabalin for neuropathic pain in adults.
Derry S, Bell RF, Straube S, et al.
The Cochrane database of systematic reviews 2019; (1()):CD007076 doi:10.1002/14651858.CD007076.pub3.
PMID: 30673120 - 6
Gabapentin for Chronic Neuropathic Pain.
Moore A, Derry S, Wiffen P
JAMA 2018; (319(8)):818-819 doi:10.1001/jama.2017.21547.
PMID: 29486015 - 7
Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.
Mallick-Searle T, Snodgrass B, Brant JM
Journal of multidisciplinary healthcare 2016; (9()):447-454 doi:10.2147/JMDH.S106340.
PMID: 27703368 - 8
Modalities in managing postherpetic neuralgia.
Shrestha M, Chen A
The Korean journal of pain 2018; (31(4)):235-243 doi:10.3344/kjp.2018.31.4.235.
PMID: 30310548 - 9
PEER systematic review of randomized controlled trials: Management of chronic neuropathic pain in primary care.
Falk J, Thomas B, Kirkwood J, et al.
Canadian family physician Medecin de famille canadien 2021; (67(5)):e130-e140 doi:10.46747/cfp.6705e130.
PMID: 33980642 - 10
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability.
Navez ML, Monella C, Bösl I, et al.
Pain and therapy 2015; (4(1)):1-15 doi:10.1007/s40122-015-0034-x.
PMID: 25896574 - 11
The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence.
de León-Casasola OA, Mayoral V
Journal of pain research 2016; (9()):67-79 doi:10.2147/JPR.S99231.
PMID: 26929664 - 12
Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia.
Wang A, Li H, Xie Z, et al.
Dermatology and therapy 2023; (13(7)):1477-1487 doi:10.1007/s13555-023-00938-8.
PMID: 37268784 - 13
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S, Rice AS, Cole P, et al.
The Cochrane database of systematic reviews 2017; (1()):CD007393 doi:10.1002/14651858.CD007393.pub4.
PMID: 28085183 - 14
Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability.
Laklouk M, Baranidharan G
Patient preference and adherence 2016; (10()):1913-1918 doi:10.2147/PPA.S76506.
PMID: 27703336 - 15
Interventional Treatments for Postherpetic Neuralgia: A Systematic Review.
Lin CS, Lin YC, Lao HC, Chen CC
Pain physician 2019; (22(3)):209-228.
PMID: 31151330 - 16
Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia.
Gudin J, Fudin J, Wang E, et al.
Journal of managed care & specialty pharmacy 2019; (25(12)):1387-1396 doi:10.18553/jmcp.2019.19093.
PMID: 31589557 - 17
Efficacy and safety of gabapentinoid combination therapy versus monotherapy for the treatment of neuropathic pain.
Li D, He Y, Fan Z, et al.
Frontiers in physiology 2026; (17()):1802999 doi:10.3389/fphys.2026.1802999.
PMID: 42051748
This page explains medication and topical treatment options for postherpetic neuralgia for informational purposes only and is not medical advice. Your prescriber should choose doses, monitor side effects, and guide any medication taper.
Get notified when new evidence is published on post-infectious neuralgia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.